AU500889B2 - Metabolites 27481/f-1 & f-2 - Google Patents

Metabolites 27481/f-1 & f-2

Info

Publication number
AU500889B2
AU500889B2 AU76081/74A AU7608174A AU500889B2 AU 500889 B2 AU500889 B2 AU 500889B2 AU 76081/74 A AU76081/74 A AU 76081/74A AU 7608174 A AU7608174 A AU 7608174A AU 500889 B2 AU500889 B2 AU 500889B2
Authority
AU
Australia
Prior art keywords
metabolites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU76081/74A
Other languages
English (en)
Other versions
AU7608174A (en
Inventor
E. & Ruegger A Harri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25713544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU500889(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH1711173A external-priority patent/CH589716A5/de
Priority claimed from CH1404374A external-priority patent/CH603790A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7608174A publication Critical patent/AU7608174A/en
Application granted granted Critical
Publication of AU500889B2 publication Critical patent/AU500889B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/06—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungal isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/885—Trichoderma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AU76081/74A 1973-12-06 1974-12-04 Metabolites 27481/f-1 & f-2 Expired AU500889B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1711173A CH589716A5 (en) 1973-12-06 1973-12-06 Antibiotics S 7481-F-1 and 2 - prepd. from new strains of Cylindrocarbon or Trichoderma esp. useful as immunosuppressant
CHCH17111/73 1973-12-06
CH1404374A CH603790A5 (en) 1974-10-21 1974-10-21 Antibiotics S 7481-F-1 and 2
CHCH14043/74 1974-10-21

Publications (2)

Publication Number Publication Date
AU7608174A AU7608174A (en) 1976-06-10
AU500889B2 true AU500889B2 (en) 1979-06-07

Family

ID=25713544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76081/74A Expired AU500889B2 (en) 1973-12-06 1974-12-04 Metabolites 27481/f-1 & f-2

Country Status (19)

Country Link
JP (1) JPS5615235B2 (de)
AU (1) AU500889B2 (de)
CA (1) CA1030469A (de)
DD (1) DD115695A5 (de)
DE (2) DE2463138C2 (de)
DK (1) DK136780B (de)
ES (1) ES432559A1 (de)
FI (2) FI52851C (de)
FR (1) FR2253531B1 (de)
GB (1) GB1491509A (de)
HK (1) HK53880A (de)
IE (1) IE40549B1 (de)
IL (1) IL46180A (de)
MY (1) MY8100203A (de)
NL (1) NL179220C (de)
NO (1) NO744292L (de)
NZ (1) NZ176117A (de)
PH (1) PH13773A (de)
SE (1) SE423720B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614931A5 (de) 1975-11-04 1979-12-28 Sandoz Ag
US4117118A (en) * 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
SE445174B (sv) * 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
SE448386B (sv) * 1978-10-18 1987-02-16 Sandoz Ag Nya cyklosporinderivat, forfarande for framstellning av dem samt farmaceutisk komposition innehallande dem
EP0034567B1 (de) * 1980-02-14 1984-11-07 Sandoz Ag Verfahren zur Totalsynthese von Cyclosporinen und neue Cyclosporine
US4396542A (en) 1980-02-14 1983-08-02 Sandoz Ltd. Method for the total synthesis of cyclosporins, novel cyclosporins and novel intermediates and methods for their production
US4384996A (en) 1981-01-09 1983-05-24 Sandoz Ltd. Novel cyclosporins
JPS59129920U (ja) * 1983-02-16 1984-08-31 日立造船株式会社 ゲ−ト付バイパスバルブの開閉操作装置
GB8717300D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Cyclosporins
FI111730B (fi) 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
DE69222150T2 (de) * 1991-01-25 1998-01-15 Fujisawa Pharmaceutical Co Prozess zur produktion von cyclosporin-a und/oder c
KR100304324B1 (ko) * 1994-10-13 2001-11-22 김용규 사이클로스포린a의제조방법
WO1996014079A1 (de) 1994-11-03 1996-05-17 Arzneimittelwerk Dresden Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US6423233B1 (en) 2000-08-15 2002-07-23 Biogal Gyogyszergyar Rt. Purification process
AU2004222306A1 (en) 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
US7511013B2 (en) 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
EP1809656A4 (de) 2004-09-29 2009-03-25 Amr Technology Inc Cyclosporinalkinanaloga und deren pharmazeutische anwendungen
US7361636B2 (en) 2004-10-06 2008-04-22 Amr Technology, Inc. Cyclosporin alkynes and their utility as pharmaceutical agents
US7696166B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
EP2151450A1 (de) * 2008-07-29 2010-02-10 Sandoz AG Verfahren zur Aufarbeitung von mikrobiologisch hergestellten zyklischen Oligopeptiden

Also Published As

Publication number Publication date
NL7415682A (nl) 1975-06-10
SE423720B (sv) 1982-05-24
CA1030469A (en) 1978-05-02
SE7415027L (de) 1975-06-09
NO744292L (de) 1975-06-30
FR2253531B1 (de) 1978-07-21
GB1491509A (en) 1977-11-09
DE2463138C2 (de) 1984-07-05
DE2455859A1 (de) 1975-06-12
FI52851B (de) 1977-08-31
NL179220C (nl) 1986-08-01
FI52851C (fi) 1977-12-12
DK136780B (da) 1977-11-21
DD115695A5 (de) 1975-10-12
JPS5615235B2 (de) 1981-04-09
FI54606C (fi) 1979-01-10
FI343474A (de) 1975-06-07
HK53880A (en) 1980-10-03
IE40549B1 (en) 1979-06-20
NL179220B (nl) 1986-03-03
JPS5089598A (de) 1975-07-18
ES432559A1 (es) 1977-03-01
PH13773A (en) 1980-09-23
DE2455859C2 (de) 1983-12-15
MY8100203A (en) 1981-12-31
IL46180A (en) 1978-07-31
DK136780C (de) 1978-05-01
NZ176117A (en) 1981-05-01
IL46180A0 (en) 1975-03-13
DK617074A (de) 1975-07-28
FI54606B (fi) 1978-09-29
IE40549L (en) 1975-06-06
AU7608174A (en) 1976-06-10
FI771201A (de) 1977-04-15
FR2253531A1 (de) 1975-07-04

Similar Documents

Publication Publication Date Title
AU474137B2 (en) Auto-refractometer
AU500889B2 (en) Metabolites 27481/f-1 & f-2
AU468964B2 (en) Melik
CA1019217A (en) Osteotome
CA1023739A (en) N-(3-hydroxyaryl-propyl)-imides
CA1016963A (en) Alumina-chrome refractory
CA986736A (en) Foundations
CA994351A (en) Tetrahydronaphthyloxy-amines and related compounds
AU472276B2 (en) Camparator circuitry
AU476397B2 (en) A-cycloalkylbenzyl lactamimides
CA999964A (en) Loudspeaker
AU476505B2 (en) Alkylbenxyl lactamimides
CA1016181A (en) Substituted pyrrolidinemethanols
AU472907B2 (en) Firecheck
CA1034943A (en) Substituted phenylglycylcephalosporins
CA1011527A (en) Anchor assembly
CA1026331A (en) Substituted indolobenzazepines
CA1022943A (en) Substituted ureido-s-triazines
AU473700B2 (en) New thiadiazolylimidazolidinones
AU476386B2 (en) Dibenzocycloheptenyl lactamimides
CA998297A (en) Anchors
AU471241B2 (en) Benzothiazolylureas
AU477508B2 (en) Anchor
CA969746A (en) Pledgets
AU481104B2 (en) Substituted benzoylacrylanilides